Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.00
Bid: 195.00
Ask: 196.00
Change: 6.00 (3.16%)
Spread: 1.00 (0.513%)
Open: 190.20
High: 197.40
Low: 189.20
Prev. Close: 190.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR and PCA Shareholding

29 Jun 2017 13:53

RNS Number : 6157J
Advanced Medical Solutions Grp PLC
29 June 2017
 

29 June 2017

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

 

Director/PDMR and PCA Shareholding

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 26 June 2017 that Chris Meredith, who is a Director and PDMR, following the successful achievement of certain performance criteria, has exercised 162,069 options from the Long Term Incentive Plan (LTIP). Mr Meredith subsequently sold 76,604 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on this exercise. 

 

As a result of these transactions Chris Meredith's beneficial interest in the Company has increased from 1,384,841 shares to 1,470,306 shares.

 

Long Term Incentive Plan (LTIP)

 

Director

No. of LTIPs prior to exercise

LTIPs exercised

Ordinary Shares sold

Ordinary shares retained

LTIPs after exercise

Chris Meredith,

Chief Executive Officer

583,509

162,069

76,604

85,465

421,440

 

Overall Holding

 

Director

Holding prior to exercise

Number of shares exercised

Number of shares sold

Sale price (p)

Resultant holding

% of issued share capital

Chris Meredith, Chief

Executive Officer

1,384,841

162,069

76,604

301.8015p

1,470,306

0.69%

 

The Company further announces that it was notified on 26 June 2017 that Mary Tavener, who is a Director and PDMR, following the successful achievement of certain performance criteria, has exercised 162,069 options from the Long Term Incentive Plan (LTIP). Mrs Tavener subsequently sold 54,519 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on this exercise.

 

As a result of these transactions Mary Tavener's beneficial interest in the Company has increased from 1,890,647 shares to 1,954,191 shares.

 

 

 

 

 

Long Term Incentive Plan (LTIP)

 

Director

No. of LTIPs prior to exercise

LTIPs exercised

Ordinary Shares sold

Ordinary shares retained

LTIPs after exercise

Mary Tavener,

Chief Financial Officer

442,265

114,440

54,519

63,544

327,825

 

Overall Holding

 

Director

Holding prior to exercise

Number of shares exercised

Number of shares sold

Sale price (p)

Resultant holding

% of issued share capital

Mary Tavener, Chief

Financial Officer

1,890,647

114,440

54,519

301.8015p

1,954,191

0.92%

 

The Company further announces that it was notified on 26 June 2017 that Jeff Willis, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 38,450 options from the Long Term Incentive Plan (LTIP). Following this transaction the beneficial ownership of Jeff Willis is as follows:

 

Long Term Incentive Plan (LTIP)

 

PDMR

No. of LTIPs prior to exercise

LTIPs exercised

Ordinary shares retained

LTIPs after exercise

Jeff Willis

161,044

38,450

38,450

122,594

 

Overall Holding

 

PDMR

Holding prior to exercise

Number of shares exercised

Resultant holding

% of issued share capital

Jeff Willis

130,085

38,450

168,535

0.08%

 

The Company further announces that it was notified on 26 June 2017 that Simon Coates, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 27,783 options from the Long Term Incentive Plan (LTIP). Mr Coates has also exercised 7,888 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 17,448 Ordinary Shares of 5p each on 26 June 2017 at a share price of 301.8015p per Ordinary Share to cover the tax payable on these exercises.

 

 

 

 

Following these transactions the beneficial ownership of Simon Coates is as follows:

 

Long Term Incentive Plan (LTIP)

 

PDMR

No. of LTIPs prior to exercise

LTIPs exercised

Ordinary shares retained

LTIPs after exercise

Simon Coates

101,409

27,783

10,335

73,626

 

Deferred Share Bonus Plan (DSB)

 

PDMR

No. of DSBs prior to exercise

DSBs exercised

Ordinary Shares sold

DSBs after exercise

Simon Coates

42,825

7,888

Nil

34,937

 

Overall Holding

 

PDMR

Holding prior to exercise

Number of shares exercised

Number of shares sold

Sale price (p)

Resultant holding

% of issued share capital

Simon Coates

73,481

35,671

17,448

301.8015p

91,704

0.04%

 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Chris Meredith

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Exercise of 162,069 shares from the Long Term Incentive Plan

· Sale of 76,604 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

£3.018015

76,604

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 76,604

Aggregated price: £3.018015

e)

Date of the transaction: 26/06/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Mary Tavener

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Exercise of 199,319 shares from the Long Term Incentive Plan

· Sale of 148,423 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

£3.018015

54,519

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 54,519

Aggregated price: £3.018015

e)

Date of the transaction: 26/06/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jeff Willis

2.

Reason for the notification

a)

Position/status: Senior Manager/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transaction:

· Exercise of 38,450 shares from the Long Term Incentive Plan

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

n/a

n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 26/06/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

 

 

 

 

 

 

 

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Simon Coates

2.

Reason for the notification

a)

Position/status: Senior Manager/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

· Exercise of 27,783 shares from the Long Term Incentive Plan

· Exercise of 7,888 shares from the Deferred Share Bonus Plan

· Sale of 17,448 Ordinary Shares of 5p

c)

Price(s) and volume(s):

Sale of shares:

Price(s)

Volume(s)

£3.018015

17,448

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: 17,448

Aggregated price: £3.018015

e)

Date of the transaction: 26/06/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

 

-End -

 

 

 

 

 

 

 

 

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Chief Financial Officer

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys

AMS@consilium-comms.com

Investec Bank plc(NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Daniel Adams / Patrick Robb

 

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand® and RESORBA®.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEFRLIAFID
Date   Source Headline
28th Mar 20245:04 pmRNSTotal Voting Rights
18th Mar 202412:35 pmRNSDirector/PDMR Shareholding
13th Mar 20247:03 amRNSProposed acquisition of Peters Surgical
13th Mar 20247:03 amRNSUnaudited Preliminary Results
12th Mar 20247:00 amRNSBlock listing Interim Review
10th Jan 20247:00 amRNSFull Year Trading Update
30th Nov 20235:11 pmRNSTotal Voting Rights
31st Oct 20235:02 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSUS LiquiBand® distribution agreements signed
2nd Oct 20237:01 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of New Chair
27th Sep 20235:55 pmRNSDirector/PDMR Shareholding
25th Sep 20233:15 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSLiquiBand Fix8® US commercialisation agreement
14th Sep 20233:52 pmRNSBlock listing Interim Review
4th Sep 20237:00 amRNSTrading Statement
31st Aug 20235:56 pmRNSTotal Voting Rights
10th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20234:51 pmRNSTotal Voting Rights
11th Jul 20237:00 amRNSHalf Year Trading Update
30th Jun 20232:14 pmRNSTotal Voting Rights
19th Jun 202312:18 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSUS regulatory approval granted for LiquiBandFix8®
31st May 20232:08 pmRNSResults of Annual General Meeting
31st May 20237:00 amRNSAnnual General Meeting
22nd May 20236:13 pmRNSDirector/PDMR Shareholding
28th Apr 20235:57 pmRNSTotal Voting Rights
26th Apr 20235:37 pmRNSAnnual Report and Notice of Annual General Meeting
18th Apr 20236:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:41 pmRNSTotal Voting Rights
27th Mar 20235:56 pmRNSDirector/PDMR and PCA Shareholding
22nd Mar 20235:52 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSUnaudited Preliminary Results
8th Mar 20232:56 pmRNSBlock listing announcement
28th Feb 20235:56 pmRNSTotal Voting Rights
14th Feb 20237:01 amRNSNotice of Results
1st Feb 20231:30 pmRNSAcquisition of Connexicon Medical
31st Jan 20233:17 pmRNSTotal Voting Rights
10th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
30th Nov 20226:04 pmRNSTotal Voting Rights
28th Nov 20224:20 pmRNSChange of Registrar
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA
14th Sep 20227:00 amRNSInterim Results
8th Sep 20224:53 pmRNSBlock listing announcement
17th Aug 20227:00 amRNSNotice of Interim Results
1st Aug 20227:00 amRNSDirectorate Change
6th Jul 20227:00 amRNSHalf Year Trading Update
8th Jun 20221:52 pmRNSResults of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.